Kansai Medical University
Osaka, 570-8506, Japan
NCT Number: NCT00436111
The purpose of this study is to clarify the nature of macroprolactin which has recently been highlighted because of the high prevalence and a diagnostic pitfall of hyperprolactinemia. The results of this study are beneficial for the patients to whom unnecessary medications and unnecessary radiological examinations have been performed.
We used the remained serum samples taken for routine prolactin determination during the past several years. Since the blood was basically taken to examine the causes of hyperprolactinemia and only remained serum samples were used for this study, the Ethics Committee of Kobe City General Hospital judged that it was not required to obtain approval number.
Looking for future studies?
Notify MeAll sexes
Observational
Osaka, 570-8506, Japan
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Kansai Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05033119
Antipsychotics and Neuroleptics Toxicity, Brain Diseases
Aalborg, Denmark
View Trial DetailsNCT04746313
Brain Diseases, Central Nervous System Diseases
Lille, France
View Trial DetailsNCT02956447
Brain Diseases, Central Nervous System Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT00914823
Adnexal Diseases, Brain Diseases
Boston, Massachusetts, United States
View Trial Details